Avail Medsystems

Avail Medsystems is a pioneering medical technology company that provides cost-effective solutions connecting procedural healthcare professionals regardless of location. The company aims to democratize access to clinical and procedural expertise by removing physical, economic, and logistical barriers through their Procedural TelemedicineTM solution. Founded in 2017 and headquartered in the United States, Avail Medsystems recently secured a $100.00M Series B investment on October 7, 2020 from 8VC and D1 Capital Partners. The company's innovative approach addresses the challenges of in-person collaboration, offering on-the-go collaboration with high-definition cameras and external imaging equipment. This solution not only enhances procedural collaboration but also expedites the training of providers on latest medical device technologies, ultimately revolutionizing the healthcare industry.